InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,742.58
(
0.36%
)
US TECH 100
19,596.01
(
0.84%
)
Dow Jones
42,136.06
(
0.53%
)
Brent Oil
70.77
(
-3.31%
)
Bitcoin
65,182.06
(
3.23%
)
Post# of 3203
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

IamnotTylerDurden

Send PM Follow Ignore
Followers 8
Posts 617
Boards Moderated 0
Alias Born 12/07/2016

IamnotTylerDurden

Re: semi_infinite post# 2621

Monday, 05/07/2018 7:52:13 AM

Monday, May 07, 2018 7:52:13 AM

Post# of 3203
They were a few questions about FDA and safety but they responded that they don't expected any additional reviews to have any impact on current sales or on adding new patients, as the there is already a warning on the drug as is. The drug was approved with the benefits outweighing the risks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ACAD News
More ACAD News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!